Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Fish and Richardson
Cantor Fitzgerald
Argus Health
US Department of Justice

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018058

« Back to Dashboard

NDA 018058 describes GALLIUM CITRATE GA 67, which is a drug marketed by Ge Healthcare, Lantheus Medcl, and Mallinkrodt Nuclear, and is included in three NDAs. It is available from two suppliers. Additional details are available on the GALLIUM CITRATE GA 67 profile page.

The generic ingredient in GALLIUM CITRATE GA 67 is gallium citrate ga-67. There are fifteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the gallium citrate ga-67 profile page.

Summary for 018058

Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 018058

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
GALLIUM CITRATE GA 67 gallium citrate ga-67 INJECTABLE;INJECTION 018058 NDA MALLINCKRODT NUCLEAR MEDICINE LLC 69945-180 69945-180-12 1 VIAL in 1 CAN (69945-180-12) > 6.6 mL in 1 VIAL
GALLIUM CITRATE GA 67 gallium citrate ga-67 INJECTABLE;INJECTION 018058 NDA MALLINCKRODT NUCLEAR MEDICINE LLC 69945-180 69945-180-06 1 VIAL in 1 CAN (69945-180-06) > 3.3 mL in 1 VIAL

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength2mCi/ML
Approval Date:Approved Prior to Jan 1, 1982TE:BSRLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Chinese Patent Office
Cantor Fitzgerald
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: